HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagement

Clin Immunol. 2004 Mar;110(3):243-51. doi: 10.1016/j.clim.2003.11.014.

Abstract

Recent advances in molecular medicine have shown that soluble MHC-multimers can be valuable tools for both the stimulation of as well as the analysis of antigen-specific T cells in vitro. In this review, we describe the use of dimeric major histocompatibility complexes, HLA-Ig, to visualize antigen-specific T cells as well as their potential to stimulate immune responses as part of an artificial antigen-presenting cell (aAPC). The use of HLA-Ig-based aAPC represents an exciting new approach to generate antigen-specific CTL for adoptive immunotherapy that helps to overcome many of the obstacles associated with limitations in current approaches to adoptive immunotherapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antigen-Presenting Cells / immunology*
  • Antigens / immunology
  • HLA-A2 Antigen / immunology*
  • Humans
  • Immunoglobulins / chemistry
  • Immunoglobulins / immunology*
  • Lymphocyte Activation / immunology*
  • Macromolecular Substances
  • T-Lymphocytes, Cytotoxic / immunology*

Substances

  • Antigens
  • HLA-A2 Antigen
  • Immunoglobulins
  • Macromolecular Substances